GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Price-to-Owner-Earnings

Medicure (TSXV:MPH) Price-to-Owner-Earnings : 13.43 (As of May. 24, 2025)


View and export this data going back to 1999. Start your Free Trial

What is Medicure Price-to-Owner-Earnings?

As of today (2025-05-24), Medicure's share price is C$0.94. Medicure's Owner Earnings per Share (TTM) ended in Mar. 2025 was C$0.07. It's Price-to-Owner-Earnings for today is 13.43.


The historical rank and industry rank for Medicure's Price-to-Owner-Earnings or its related term are showing as below:

TSXV:MPH' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 1.25   Med: 9.36   Max: 194.26
Current: 13.24

During the past 13 years, the highest Price-to-Owner-Earnings of Medicure was 194.26. The lowest was 1.25. And the median was 9.36.


TSXV:MPH's Price-to-Owner-Earnings is ranked better than
72.71% of 447 companies
in the Drug Manufacturers industry
Industry Median: 24.63 vs TSXV:MPH: 13.24

As of today (2025-05-24), Medicure's share price is C$0.94. Medicure's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was C$-0.17. Therefore, Medicure's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-24), Medicure's share price is C$0.94. Medicure's EPS without NRI for the trailing twelve months (TTM) ended in was C$-0.16. Therefore, Medicure's PE Ratio without NRI for today is At Loss.

During the past 13 years, Medicure's highest PE Ratio without NRI was 167.60. The lowest was 0.00. And the median was 13.93.


Medicure Price-to-Owner-Earnings Historical Data

The historical data trend for Medicure's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure Price-to-Owner-Earnings Chart

Medicure Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 12.39

Medicure Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 10.74 12.39 -

Competitive Comparison of Medicure's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Medicure's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicure's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicure's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Medicure's Price-to-Owner-Earnings falls into.


;
;

Medicure Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Medicure's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.94/0.07
=13.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicure  (TSXV:MPH) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Medicure Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Medicure's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicure Business Description

Traded in Other Exchanges
Address
2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6
Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.
Executives
Albert David Friesen Director, Senior Officer
Neil Wayne Owens Senior Officer
David Gurvey Senior Officer

Medicure Headlines

No Headlines